DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Melinda Wharton - 3 Dr - 2 Novavax - 2 ” - 1 Susan Hariri - 1 Archana Chatterjee - 1 Chatterjee - 1 they’re - 1
Top related locs:
Novavax U.S United States Canada COVID Chicago , Illinois The U.S
Top related orgs:
FDA - 3 National Center - 3 Pfizer - 2 Moderna - 2 Centers for Disease Control - 2 CNN - 1 US Centers for Disease Control - 1 CDC’s National Center - 1

Search resuls for: "Melinda Wharton"


3 mentions found


☆ Whooping cough cases are soaring. Can infecting people help test a better vaccine?
  + stars: | 2024-09-20 | by ( Brenda Goodman | Deidre Mcphillips | ) edition.cnn.com   time to read: +8 min
Whooping cough cases climbing for decadesAs with many infectious diseases, cases of whooping cough dropped to unusually low levels during the pandemic as people limited social interactions and took other precautions to defend against Covid-19. In 2020, the US had about 6,000 cases of pertussis, and that number dropped even further in 2021 to roughly 2,000 cases. Whooping cough starts with symptoms that look a lot like a regular cold: a runny nose, sneezing, a low-grade fever and a tickly cough. That’s led to a hunt for better, more durable immunizations against whooping cough that also don’t cause as many side effects. In some ways, whooping cough is an ideal infection to test in human challenge models.
Persons: ”, Susan Hariri, Archana Chatterjee, Chatterjee, they’re, it’s, pertussis –, Hariri, Tod Merkel, Merkel, It’s, That’s, Dr, Sanjay Gupta, Melinda Wharton Organizations: CNN, US Centers for Disease Control, CDC’s National Center, Food and Drug Administration, Chicago Medical School, Products Advisory, Covid, FDA’s, Vaccines Research, Regulators, CNN Health, FDA, National Center Locations: United States, Canada
☆ Pfizer, Moderna and Novavax gear up for fall Covid vaccine rollout with an important head start
  + stars: | 2023-06-20 | by ( Annika Kim Constantino | ) www.cnbc.com   time to read: +4 min
But facing pressure to deliver new shots by the fall, Pfizer, Moderna and Novavax began development on versions of their vaccines targeting XBB.1.5 months before the FDA's decision. That doesn't include Johnson & Johnson , a once-leading Covid vaccine developer. Moderna expects a minimum of $5 billion in revenue from its Covid vaccine, its only available product. The cash-strapped company won U.S. approval for its Covid vaccine under emergency use just last year due to regulatory and manufacturing delays. The company hopes to rake in $1.06 billion to $1.24 billion in sales of its Covid vaccine this year.
Persons: Novavax, Dr, Melinda Wharton, Johnson Organizations: Chicago Department of Public Health, Southwest Senior Center, The U.S . Food, Pfizer, Moderna, FDA, Centers for Disease Control, National Center, Manufacturers, U.S, Moderna's Locations: COVID, Chicago , Illinois, The U.S, Novavax, U.S
☆ FDA advisors recommend that new Covid vaccines target an omicron XBB variant this fall
  + stars: | 2023-06-15 | by ( Annika Kim Constantino | ) www.cnbc.com   time to read: +4 min
The committee unanimously voted that the new jabs should be monovalent — meaning they are designed to protect against one variant of Covid — and target a member of the XBB family. Those strains of Covid are descendants of the omicron variant, which caused cases to surge to record levels early last year. Advisors also generally agreed that the new shots should specifically target a variant called XBB.1.5. There is also uncertainty about which age groups the FDA and CDC will advise to receive the updated shots this fall. But it's unclear how many Americans will roll up their sleeves to take the updated shots later this year.
Persons: Melinda Wharton, Novavax, John Jacobs, Peter Marks, David Kaslow Organizations: . Food, Centers for Disease Control, Advisors, Pfizer, Moderna, National Center, FDA, CDC, Novavax, omicron Locations: U.S, Novavax
0 next >>
Total: 3